관리-도구

편집 파일: 1625416134.M227777P17413.server.saraya-global.com,S=48516,W=50282:2,

Envelope-to: info@worldwide.saraya.com
Delivery-date: Mon, 05 Jul 2021 00:28:54 +0800
To: info@worldwide.saraya.com
Date: Sun, 4 Jul 2021 16:26:53 +0000
From: PMC Transactions AG <news@licensing4pharma.com>
Reply-To: PMC Transactions AG <news@licensing4pharma.com>
Message-ID: <tT4F8WnJSYDAqTeTGs97I4L1SqluVZa0whKJb3iAw@www.pmc-transactions.com>
MIME-Version: 1.0
Content-Type: multipart/alternative;
 boundary="b1_tT4F8WnJSYDAqTeTGs97I4L1SqluVZa0whKJb3iAw"
Content-Transfer-Encoding: 8bit
Subject: ***SPAM*** Divestments

This is a multi-part message in MIME format.

--b1_tT4F8WnJSYDAqTeTGs97I4L1SqluVZa0whKJb3iAw
Content-Type: text/plain; charset=iso-8859-1
Content-Transfer-Encoding: 8bit

Dear Madam, Dear Sir,

We would like to inform you that we can offer the following business opportunities for purchase or partnering:

I. Business Opportunities - Company Sales

#1
			�
		
		
			Project Name: 
			Vienna
		
		
			Headline:
			Company in Dermatology and Dermocosmetics
		
		
			Business Description:
			The company for sale is a well-established company specializing in the marketing and distribution of specific dermatological products and cosmetics through a large sales force team to doctors, hospitals and pharmacies.
		
		
			Transaction Type:
			Company Sale
		
		
			Industry Sector:
			Pharma / Healthcare,OTC Drugs,Rx Drugs
		
		
			Therapeutic Class:
			Dermatology
		
		
			Continents:
			Europe
		
		
			Regions:
			Western Europe
		
		
			Counties:
			Austria,Germany,Liechtenstein,Switzerland
		
		
			Revenue-Range:
			10-50 m EUR
		
		
			EBITDA-Margin:
			16.7 %